Valeo Pharma Inc.
VPHIF · OTC
7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $7 | $10 | $8 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $5 | $5 | $5 | $6 |
| Inventory | $5 | $7 | $10 | $10 |
| Other Curr. Assets | $2 | $1 | $1 | $1 |
| Total Curr. Assets | $19 | $20 | $25 | $25 |
| Property Plant & Equip (Net) | $2 | $3 | $3 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $10 | $12 | $13 | $13 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | $0 | $0 |
| Total NC Assets | $13 | $14 | $15 | $16 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $32 | $35 | $40 | $41 |
| Liabilities | – | – | – | – |
| Payables | $10 | $9 | $10 | $4 |
| Short-Term Debt | $46 | $39 | $31 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | -$0 | $0 | $0 | $0 |
| Other Curr. Liab. | $14 | $2 | $11 | $12 |
| Total Curr. Liab. | $70 | $50 | $52 | $20 |
| LT Debt | $24 | $29 | $36 | $60 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $10 | $0 | $1 |
| Total NC Liab. | $25 | $39 | $36 | $61 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $95 | $89 | $87 | $82 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $32 | $32 | $32 | $32 |
| Retained Earnings | -$105 | -$97 | -$89 | -$82 |
| AOCI | -$0 | $6 | $6 | -$0 |
| Other Equity | $11 | $5 | $5 | $11 |
| Total Equity | -$63 | -$55 | -$47 | -$40 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $32 | $35 | $40 | $41 |
| Net Debt | $63 | $61 | $57 | $58 |